Dexcom alerts users after faulty G7 glucose sensors stolen and resold

People with diabetes who use the Dexcom G7 continuous glucose monitoring system need to check the lot numbers on sensors. Dexcom reported on May 26, 2026, that through internal reviews it had ...
Medical Device and Diagnostic Industry (MD+DI)Opinion

Dexcom Learns a Lesson in Transparency

Customers have known for months that the Dexcom G7 continuous glucose monitoring sensor had problems. Now, the company is ...
TechRepublic

Dexcom Warns Stolen G7 Glucose Sensors May Pose Infection, Reading Risks

Dexcom says stolen G7 sensors from two scrapped lots were sold through unauthorized channels, creating infection and reading-failure risks. Medical device maker Dexcom says two lots of its Dexcom G7 ...
Benzinga.com

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...

Dexcom bolsters evidence for glucose sensors for Type 2 diabetes

New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said ...
Endocrinology Advisor

Dexcom Stelo Becomes First OTC Continuous Glucose Monitor for Kids

The FDA expanded clearance of Dexcom's Stelo Glucose Biosensor System to individuals aged 2 years and older who do not use insulin.